Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Senators Join Biosimilar Coding Debate, Ask CMS To Withhold Draft Policy

This article was originally published in The Pink Sheet Daily

Executive Summary

A bipartisan group of 20 US senators wrote to the Centers for Medicare and Medicaid Services asking that it not issue rules on how Medicare will reimburse biosimilars until the Food and Drug Administration has completed its regulations for the products.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS077974

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel